$MANH
Manhattan Associates Inc

2013 Q2 Form 10-Q Financial Statement

#000119312513312687 Filed on July 31, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $102.5M $93.57M
YoY Change 9.56% 5.84%
Cost Of Revenue $44.02M $39.35M
YoY Change 11.86% 10.09%
Gross Profit $58.50M $54.22M
YoY Change 7.9% 2.96%
Gross Profit Margin 57.06% 57.94%
Selling, General & Admin $19.82M $20.66M
YoY Change -4.04% -4.14%
% of Gross Profit 33.88% 38.1%
Research & Development $11.03M $10.80M
YoY Change 2.13% 1.18%
% of Gross Profit 18.86% 19.92%
Depreciation & Amortization $1.459M $1.418M
YoY Change 2.89% -36.21%
% of Gross Profit 2.49% 2.62%
Operating Expenses $30.85M $31.46M
YoY Change -1.92% -2.38%
Operating Profit $26.19M $21.34M
YoY Change 22.7% 17.18%
Interest Expense $1.200M $800.0K
YoY Change 50.0% 166.67%
% of Operating Profit 4.58% 3.75%
Other Income/Expense, Net $1.243M $802.0K
YoY Change 54.99% 140.12%
Pretax Income $27.43M $22.14M
YoY Change 23.87% 19.39%
Income Tax $10.02M $7.972M
% Of Pretax Income 36.54% 36.0%
Net Earnings $17.41M $14.17M
YoY Change 22.83% 14.86%
Net Earnings / Revenue 16.98% 15.15%
Basic Earnings Per Share $0.23 $0.18
Diluted Earnings Per Share $0.22 $0.18
COMMON SHARES
Basic Shares Outstanding 76.89M 79.06M shares
Diluted Shares Outstanding 78.04M 81.40M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.5M $100.9M
YoY Change 5.55% -7.77%
Cash & Equivalents $98.62M $95.09M
Short-Term Investments $7.900M $5.800M
Other Short-Term Assets $15.40M $15.10M
YoY Change 1.99% 4.14%
Inventory
Prepaid Expenses
Receivables $68.47M $64.44M
Other Receivables $0.00 $0.00
Total Short-Term Assets $190.4M $180.4M
YoY Change 5.51% 1.13%
LONG-TERM ASSETS
Property, Plant & Equipment $14.17M $13.77M
YoY Change 2.91% 1.99%
Goodwill $62.26M $62.26M
YoY Change 0.01%
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $2.100M $5.500M
YoY Change -61.82% -55.28%
Total Long-Term Assets $78.49M $81.49M
YoY Change -3.68% -8.85%
TOTAL ASSETS
Total Short-Term Assets $190.4M $180.4M
Total Long-Term Assets $78.49M $81.49M
Total Assets $268.8M $261.9M
YoY Change 2.65% -2.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.380M $8.087M
YoY Change -8.74% -9.13%
Accrued Expenses $24.50M $26.70M
YoY Change -8.24% -4.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.81M $89.71M
YoY Change 1.23% 2.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.63M $8.900M
YoY Change 19.39% -10.1%
Total Long-Term Liabilities $10.63M $8.900M
YoY Change 19.39% -10.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.81M $89.71M
Total Long-Term Liabilities $10.63M $8.900M
Total Liabilities $101.4M $98.60M
YoY Change 2.88% 1.54%
SHAREHOLDERS EQUITY
Retained Earnings $174.8M $168.9M
YoY Change 3.48%
Common Stock $193.0K $200.0K
YoY Change -3.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $167.4M $163.3M
YoY Change
Total Liabilities & Shareholders Equity $268.8M $261.9M
YoY Change 2.65% -2.2%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $17.41M $14.17M
YoY Change 22.83% 14.86%
Depreciation, Depletion And Amortization $1.459M $1.418M
YoY Change 2.89% -36.21%
Cash From Operating Activities $13.60M $20.90M
YoY Change -34.93% 30.63%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$1.500M
YoY Change -33.33% 114.29%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$900.0K
YoY Change 11.11% -1000.0%
Cash From Investing Activities -$2.000M -$2.300M
YoY Change -13.04% 360.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.50M -14.50M
YoY Change -13.79% -39.33%
NET CHANGE
Cash From Operating Activities 13.60M 20.90M
Cash From Investing Activities -2.000M -2.300M
Cash From Financing Activities -12.50M -14.50M
Net Change In Cash -900.0K 4.100M
YoY Change -121.95% -148.81%
FREE CASH FLOW
Cash From Operating Activities $13.60M $20.90M
Capital Expenditures -$1.000M -$1.500M
Free Cash Flow $14.60M $22.40M
YoY Change -34.82% 34.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19312084 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95092000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8456000
CY2013Q2 us-gaap Goodwill
Goodwill
62262000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16720000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6915000
CY2013Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
167406000
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4482000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14699000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19308861 shares
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7380000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
1382000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
54494000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10626000
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
678000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
174768000
CY2013Q2 us-gaap Assets
Assets
268841000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68469000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
268841000
CY2013Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
40400000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98623000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19308861 shares
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7555000
CY2013Q2 us-gaap Cash
Cash
58200000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
90809000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5262000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
186193 shares
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
7887000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
193000
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Assets Current
AssetsCurrent
190350000
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14169000
CY2013Q2 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
9754000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92180000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8571000
CY2012Q4 us-gaap Goodwill
Goodwill
62265000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
7787000
CY2012Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
161509000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4024000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91141000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6235000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
371750 shares
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
6310000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19620967 shares
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10229000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
1659000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
196000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Assets Current
AssetsCurrent
181507000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15650000
CY2012Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
12233000
dei Trading Symbol
TradingSymbol
MANH
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
47935000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9163000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
732000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
166016000
CY2012Q4 us-gaap Assets
Assets
261813000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62102000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
261813000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96737000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19620967 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4703000
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN ASSOCIATES INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001056696
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Costs And Expenses
CostsAndExpenses
153269000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
13237000
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.03
us-gaap Costs And Expenses
CostsAndExpenses
145766000
us-gaap Operating Income Loss
OperatingIncomeLoss
39282000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
53000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
678000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24932000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3688000
us-gaap Operating Income Loss
OperatingIncomeLoss
45848000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1394000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27910000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
211292 shares
us-gaap Maintenance Revenue
MaintenanceRevenue
51447000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2943000
us-gaap Share Based Compensation
ShareBasedCompensation
4040000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.57
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7341000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
179651 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34902000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
323000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.349 pure
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3861000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33696000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7142000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
101643000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
159000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1633000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1886000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17440000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-227000
us-gaap Restricted Stock Expense
RestrictedStockExpense
3900000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19597000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
199117000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6971000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2852000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47242000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23322000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2852000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.60
us-gaap Licenses Revenue
LicensesRevenue
30381000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22508000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26167000
us-gaap Cost Of Revenue
CostOfRevenue
87056000
us-gaap Operating Expenses
OperatingExpenses
63270000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4874000
us-gaap Cost Of Services
CostOfServices
70104000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
372000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19274000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5906 shares
us-gaap License Costs
LicenseCosts
3715000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
2055000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
153090000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23818000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-642000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
us-gaap Licenses Revenue
LicensesRevenue
30932000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22353000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28240000
us-gaap Cost Of Revenue
CostOfRevenue
77285000
us-gaap Operating Expenses
OperatingExpenses
65719000
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
4981000
manh Hardware Revenue And Other
HardwareRevenueAndOther
14424000
us-gaap Reimbursement Revenue
ReimbursementRevenue
7200000
us-gaap Net Income Loss
NetIncomeLoss
30762000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2265000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4874000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16480000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1955000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4062000
us-gaap Cost Of Services
CostOfServices
62032000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-173000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19834000 shares
us-gaap License Costs
LicenseCosts
3265000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-1223000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
887000
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
4987000
manh Hardware Revenue And Other
HardwareRevenueAndOther
15646000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20494000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
185048000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8206000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-734000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39960000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
139692000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000
us-gaap Reimbursement Revenue
ReimbursementRevenue
5600000
us-gaap Net Income Loss
NetIncomeLoss
25574000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2461000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
216075 shares
us-gaap Maintenance Revenue
MaintenanceRevenue
47574000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2762000
us-gaap Share Based Compensation
ShareBasedCompensation
3637000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4056000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50235000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
660000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17933000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33950000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2027000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2876000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
92118000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
260000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3250000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2912000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19548000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-650000
us-gaap Restricted Stock Expense
RestrictedStockExpense
3400000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4062000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14386000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-771000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
92000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7163000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9240000
CY2012Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
1800000
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20351000 shares
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
93567000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1822000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22144000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11415000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1730000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2012Q2 us-gaap Licenses Revenue
LicensesRevenue
15345000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10802000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
39350000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
31457000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
30322000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19765000 shares
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
69322000
CY2012Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
3200000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
14172000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7972000
CY2012Q2 us-gaap License Costs
LicenseCosts
1488000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
92000
CY2012Q2 manh Hardware Revenue And Other
HardwareRevenueAndOther
8900000
CY2012Q2 manh Cost Of Hardware And Other
CostOfHardwareAndOther
7540000
CY2012Q2 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
76329000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
26187000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1243000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
11988000
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.04
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
72225000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
21342000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
53000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
802000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12442000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
18196 shares
CY2012Q2 us-gaap Maintenance Revenue
MaintenanceRevenue
23825000
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1418000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
586000 shares
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
CY2012Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
45497000
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
140000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14635000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
17020 shares
CY2013Q2 us-gaap Maintenance Revenue
MaintenanceRevenue
25711000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1459000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
287000 shares
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365 pure
CY2013Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
52492000
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
11000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7932000
CY2013Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
2100000
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19509000 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
102516000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2772000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27430000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11888000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2772000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
16136000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11032000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
44018000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
30852000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
35058000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19222000 shares
CY2013Q2 us-gaap License Costs
LicenseCosts
1937000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
78203000
CY2013Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
3900000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
17407000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10023000
CY2013Q2 manh Hardware Revenue And Other
HardwareRevenueAndOther
8177000
CY2013Q2 manh Cost Of Hardware And Other
CostOfHardwareAndOther
7023000
CY2013Q2 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02

Files In Submission

Name View Source Status
0001193125-13-312687-index-headers.html Edgar Link pending
0001193125-13-312687-index.html Edgar Link pending
0001193125-13-312687.txt Edgar Link pending
0001193125-13-312687-xbrl.zip Edgar Link pending
d546930d10q.htm Edgar Link pending
d546930dex101b.htm Edgar Link pending
d546930dex103.htm Edgar Link pending
d546930dex311.htm Edgar Link pending
d546930dex312.htm Edgar Link pending
d546930dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g546930ex10_1bpg001.jpg Edgar Link pending
g546930ex10_3pg001.jpg Edgar Link pending
manh-20130630.xml Edgar Link completed
manh-20130630.xsd Edgar Link pending
manh-20130630_cal.xml Edgar Link unprocessable
manh-20130630_def.xml Edgar Link unprocessable
manh-20130630_lab.xml Edgar Link unprocessable
manh-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending